Pneumomediastinum, pneumatosis intestinalis and pneumoperitoneum in a patient with polymyositis: case-based review.
Melis DilbilFunda ErbasanBengisu AslanTahir Saygin ÖğütMine NokayVeli YazisizMustafa Ender TerzioĞluPublished in: Rheumatology international (2022)
Pneumomediastinum (PnM), pneumatosis intestinalis (PI), and pneumoperitoneum (PP) are rare complications of inflammatory myositis. We present a 59-year-old polymyositis (PM) patient who experienced all three complications simultaneously. The patient who presented with proximal muscle weakness, dysphagia, and weight loss was diagnosed with PM due to elevated muscle enzymes and consistent electromyography and muscle biopsy with inflammatory myopathy. On the 45th day of her immunosuppressive treatment, PnM, PI, and PP were detected incidentally in 18 F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) scan performed for severe weight loss and treatment-resistant severe disease. Since the patient had no symptoms or signs of PnM and PP, no additional intervention was applied to the current treatment, and spontaneous regression was observed in the follow-up. In addition to this case, we reviewed patients with PM who developed PBM, PP, and PI in the literature.
Keyphrases
- positron emission tomography
- computed tomography
- weight loss
- pet ct
- case report
- particulate matter
- air pollution
- pet imaging
- dual energy
- magnetic resonance imaging
- bariatric surgery
- image quality
- oxidative stress
- risk factors
- interstitial lung disease
- randomized controlled trial
- systematic review
- polycyclic aromatic hydrocarbons
- heavy metals
- type diabetes
- water soluble
- adipose tissue
- gastric bypass
- magnetic resonance
- ultrasound guided
- risk assessment